These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27914995)

  • 1. Transdermal skin patch based on reduced graphene oxide: A new approach for photothermal triggered permeation of ondansetron across porcine skin.
    Teodorescu F; Quéniat G; Foulon C; Lecoeur M; Barras A; Boulahneche S; Medjram MS; Hubert T; Abderrahmani A; Boukherroub R; Szunerits S
    J Control Release; 2017 Jan; 245():137-146. PubMed ID: 27914995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and in-vivo evaluation of ondansetron gels for transdermal delivery.
    Patel DR; Joshi A; Patel HH; Stagni G
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1030-6. PubMed ID: 24919508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal Delivery of Ondansetron Hydrochloride via Bilosomal Systems: In Vitro, Ex Vivo, and In Vivo Characterization Studies.
    Ammar HO; Mohamed MI; Tadros MI; Fouly AA
    AAPS PharmSciTech; 2018 Jul; 19(5):2276-2287. PubMed ID: 29845503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Mild Hyperthermia on Transdermal Absorption of Nicotine from Patches.
    Panda A; Sharma PK; Narasimha Murthy S
    AAPS PharmSciTech; 2019 Jan; 20(2):77. PubMed ID: 30635802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on optimizing in vitro transdermal permeation of ondansetron hydrochloride using nerodilol, carvone, and limonene as penetration enhancers.
    Krishnaiah YS; Raju V; Shiva Kumar M; Rama B; Raghumurthy V; Ramana Murthy KV
    Pharm Dev Technol; 2008; 13(3):177-85. PubMed ID: 18484486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of PEG6000 on the in vitro and in vivo transdermal permeation of ondansetron hydrochloride from EVA1802 membranes.
    Krishnaiah YS; Rama B; Raghumurthy V; Ramanamurthy KV; Satyanarayana V
    Pharm Dev Technol; 2009; 14(1):50-61. PubMed ID: 18819031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and in vitro/in vivo correlation of a drug-in-adhesive transdermal patch containing azasetron.
    Sun L; Cun D; Yuan B; Cui H; Xi H; Mu L; Chen Y; Liu C; Wang Z; Fang L
    J Pharm Sci; 2012 Dec; 101(12):4540-8. PubMed ID: 22972714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microemulsion as a tool for the transdermal delivery of ondansetron for the treatment of chemotherapy induced nausea and vomiting.
    Al Abood RM; Talegaonkar S; Tariq M; Ahmad FJ
    Colloids Surf B Biointerfaces; 2013 Jan; 101():143-51. PubMed ID: 22796784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photothermally triggered on-demand insulin release from reduced graphene oxide modified hydrogels.
    Teodorescu F; Oz Y; Quéniat G; Abderrahmani A; Foulon C; Lecoeur M; Sanyal R; Sanyal A; Boukherroub R; Szunerits S
    J Control Release; 2017 Jan; 246():164-173. PubMed ID: 27984105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.
    Silva SM; Hu L; Sousa JJ; Pais AA; Michniak-Kohn BB
    Eur J Pharm Biopharm; 2012 Apr; 80(3):663-73. PubMed ID: 22137964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Pentravan
    Bourdon F; Lecoeur M; Leconte L; Ultré V; Kouach M; Odou P; Vaccher C; Foulon C
    Int J Pharm; 2016 Dec; 515(1-2):774-787. PubMed ID: 27826027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A statistical approach to the development of a transdermal delivery system for ondansetron.
    Obata Y; Ashitaka Y; Kikuchi S; Isowa K; Takayama K
    Int J Pharm; 2010 Oct; 399(1-2):87-93. PubMed ID: 20705125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z; Teng Y; Wang H; Hou H
    Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcutaneous drug delivery by liposomes using fractional laser technology.
    Fujimoto T; Wang J; Baba K; Oki Y; Hiruta Y; Ito M; Ito S; Kanazawa H
    Lasers Surg Med; 2017 Jul; 49(5):525-532. PubMed ID: 27990655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation optimization of a drug in adhesive transdermal analgesic patch.
    Ravula R; Herwadkar AK; Abla MJ; Little J; Banga AK
    Drug Dev Ind Pharm; 2016; 42(6):862-70. PubMed ID: 26288995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrothermal patches driving the transdermal delivery of insulin.
    Pagneux Q; Ye R; Chengnan L; Barras A; Hennuyer N; Staels B; Caina D; Osses JIA; Abderrahmani A; Plaisance V; Pawlowski V; Boukherroub R; Melinte S; Szunerits S
    Nanoscale Horiz; 2020 Apr; 5(4):663-670. PubMed ID: 32226966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasmall gold nanoparticles anchored to graphene and enhanced photothermal effects by laser irradiation of gold nanostructures in graphene oxide solutions.
    Zedan AF; Moussa S; Terner J; Atkinson G; El-Shall MS
    ACS Nano; 2013 Jan; 7(1):627-36. PubMed ID: 23194145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in transdermal drug delivery performance by graphite oxide/temperature-responsive hydrogel composites with micro heater.
    Yun J; Lee DH; Im JS; Kim HI
    Mater Sci Eng C Mater Biol Appl; 2012 Aug; 32(6):1564-70. PubMed ID: 24364961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of formulation pH on transdermal penetration of antiemetics formulated in poloxamer lecithin organogel.
    Woodall R; Arnold JJ; McKay D; Asbill CS
    Int J Pharm Compd; 2013; 17(3):247-53. PubMed ID: 24046940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal delivery of ondansetron hydrochloride: effects of vehicles and penetration enhancers.
    Gwak HS; Oh IS; Chun IK
    Drug Dev Ind Pharm; 2004 Feb; 30(2):187-94. PubMed ID: 15089053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.